Home > National Drug Code (NDC) > Triple Antibiotic

Triple Antibiotic - 53329-087-01 - (bacitracin zinc, neomycin sulfate, polymyxin B sulfate)

Alphabetical Index


Drug Information of Triple Antibiotic

Product NDC: 53329-087
Proprietary Name: Triple Antibiotic
Non Proprietary Name: bacitracin zinc, neomycin sulfate, polymyxin B sulfate
Active Ingredient(s): 400; 3.5; 5000    [USP'U]/g; mg/g; [USP'U]/g & nbsp;   bacitracin zinc, neomycin sulfate, polymyxin B sulfate
Administration Route(s): TOPICAL
Dosage Form(s): OINTMENT
Coding System: National Drug Codes(NDC)

Labeler Information of Triple Antibiotic

Product NDC: 53329-087
Labeler Name: Medline Industries, Inc.
Product Type: HUMAN OTC DRUG
FDA Application Number: part333
Marketing Category: OTC MONOGRAPH NOT FINAL
Start Marketing Date: 20100401

Package Information of Triple Antibiotic

Package NDC: 53329-087-01
Package Description: 1 TUBE in 1 BOX (53329-087-01) > 28.4 g in 1 TUBE

NDC Information of Triple Antibiotic

NDC Code 53329-087-01
Proprietary Name Triple Antibiotic
Package Description 1 TUBE in 1 BOX (53329-087-01) > 28.4 g in 1 TUBE
Product NDC 53329-087
Product Type Name HUMAN OTC DRUG
Non Proprietary Name bacitracin zinc, neomycin sulfate, polymyxin B sulfate
Dosage Form Name OINTMENT
Route Name TOPICAL
Start Marketing Date 20100401
Marketing Category Name OTC MONOGRAPH NOT FINAL
Labeler Name Medline Industries, Inc.
Substance Name BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE
Strength Number 400; 3.5; 5000
Strength Unit [USP'U]/g; mg/g; [USP'U]/g
Pharmaceutical Classes

Complete Information of Triple Antibiotic


General Information